These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10624968

  • 21. Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.
    Matzdorff A, Voss R.
    Thromb Res; 2006; 117(3):307-14. PubMed ID: 15894353
    [Abstract] [Full Text] [Related]

  • 22. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
    Mousa SA, Bozarth J, Forsythe M, Tsao P, Pease L, Reilly TM.
    Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339
    [Abstract] [Full Text] [Related]

  • 23. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS, Zerwes HG, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A.
    Thromb Haemost; 1993 Sep 01; 70(3):531-9. PubMed ID: 8259560
    [Abstract] [Full Text] [Related]

  • 24. Polyamines inhibit both platelet aggregation and glycoprotein IIb/IIIa activation.
    Corona-de-la-Peña N, Uribe-Carvajal S, Barrientos-Rios R, Matias-Aguilar L, Montiel-Manzano G, Majluf-Cruz A.
    J Cardiovasc Pharmacol; 2005 Aug 01; 46(2):216-21. PubMed ID: 16044034
    [Abstract] [Full Text] [Related]

  • 25. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
    Frelinger AL, Furman MI, Krueger LA, Barnard MR, Michelson AD.
    Circulation; 2001 Sep 18; 104(12):1374-9. PubMed ID: 11560852
    [Abstract] [Full Text] [Related]

  • 26. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV, Khaspekova SG, Zabotina AM, Shimanova YV, Mazurov AV.
    Platelets; 2007 Nov 18; 18(7):506-14. PubMed ID: 17957566
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
    Lanza F, Stierlé A, Gachet C, Cazenave JP.
    Nouv Rev Fr Hematol (1978); 1992 Nov 18; 34(1):123-31. PubMed ID: 1523093
    [Abstract] [Full Text] [Related]

  • 30. Differences between platelet and microparticle glycoprotein IIb/IIIa.
    Nomura S, Suzuki M, Kido H, Yamaguchi K, Fukuroi T, Yanabu M, Soga T, Nagata H, Kokawa T, Yasunaga K.
    Cytometry; 1992 Nov 18; 13(6):621-9. PubMed ID: 1451594
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry.
    Kozek-Langenecker SA, Mohammad SF, Masaki T, Kamerath C, Cheung AK.
    Anesth Analg; 2000 Apr 18; 90(4):808-12. PubMed ID: 10735780
    [Abstract] [Full Text] [Related]

  • 33. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.
    Keating FK, Whitaker DA, Sobel BE, Schneider DJ.
    Thromb Res; 2004 Apr 18; 113(1):27-34. PubMed ID: 15081562
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N, Wakayama F, Suzuki Y, Fukui K, Takaya S, Fukuda I.
    Thromb Res; 2004 Apr 18; 113(5):303-10. PubMed ID: 15183042
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS, Raizner AE, Jordan R, Wang AL, Norton D, Mace KF, Joshi A, Coller BS, Weisman HF.
    J Am Coll Cardiol; 1995 Dec 18; 26(7):1665-71. PubMed ID: 7594101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.